The drugs industry is an enormous multibillion businesses encompassing an immense number of companies involved in the design, production and marketing of drugs worldwide. According to the type of drugs the market can be dived into the following segments: diabetes, antifungal, antidepressant, antithrombotic, hepatitis drugs, analgesics and a far more.
Currently, the drugs market is undergoing a recovery phase in the wake of the recent decline provoked by the economic slump. The market growth is spurred by increasing demand for drugs across the globe, rising incidence of chronic as well as infectious diseases, population ageing, product innovations and constant technological advancements. North America and Europe are the most prominent regional markets. Bristol-Myers Squibb, Pharmacia, GlaxoSmithKline, Merck & Co, Novartis, Eli Lilly, Pfizer, Johnson & Johnson, Allergan, Schering-Plough, Bayer and Abbott Labs are amid global drugs arena giants.
A huge collection of the research reports covering the drugs market at different geographies can be found under this MarketPublishers’ catalogue. The researches provide comprehensive assessment of the market, characterize major market trends and disclose essential market indicators. The reports describe the competitive scenario and indicate top market players. In addition, future prospects for the drugs market are thoroughly studied in the research reports.
Publications found:
9,936
Sort by:
Global Docetaxel Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032
US$ 3,480.00
... 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the Docetaxel in global market, especially in North America, Europe ... growth rate by type, application, from 2014 to 2019. Chapter 12, Docetaxel market forecast, by regions, type and application, with ...
January 2026
72 pages
Global Vinca Alkaloid Compounds Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032
US$ 3,480.00
... manufacturers of Vinca Alkaloid Compounds, with price, sales, revenue and global market share of Vinca Alkaloid Compounds in 2017 and 2018. Chapter 3, the Vinca Alkaloid Compounds competitive situation, sales, revenue and global market share ...
January 2026
111 pages
Global Iron Chelation Drug Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032
US$ 3,480.00
... manufacturers of Iron Chelation Drug, with price, sales, revenue and global market share of Iron Chelation Drug in 2017 and 2018. Chapter 3, the Iron Chelation Drug competitive situation, sales, revenue and global market share ...
January 2026
129 pages
Global Hirudin Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032
US$ 3,480.00
... from 3450 million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the Hirudin in global market, especially in North America, Europe ... growth rate by type, application, from 2014 to 2019. Chapter 12, Hirudin market forecast, by regions, type and application, with sales ...
January 2026
127 pages
Global Acetylcysteine Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032
US$ 3,480.00
... from 490 million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the Acetylcysteine in global market, especially in North America, ... growth rate by type, application, from 2014 to 2019. Chapter 12, Acetylcysteine market forecast, by regions, type and application, with ...
January 2026
110 pages
The 2027-2032 World Outlook for 3D Printed Drugs
US$ 1,195.00
This study covers the world outlook for 3D printed drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for...
January 2026
287 pages
The 2027-2032 World Outlook for Anaesthesia Drugs
US$ 1,195.00
This study covers the world outlook for anaesthesia drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), fo...
January 2026
288 pages
The 2027-2032 World Outlook for Antidiarrheal Drugs
US$ 1,195.00
This study covers the world outlook for antidiarrheal drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.),...
January 2026
287 pages
The 2027-2032 World Outlook for Antiemetics
US$ 1,195.00
This study covers the world outlook for antiemetics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the...
January 2026
287 pages
The 2027-2032 World Outlook for Branded Generics
US$ 1,195.00
This study covers the world outlook for branded generics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for...
January 2026
288 pages
The 2027-2032 World Outlook for Calcitriol
US$ 1,195.00
This study covers the world outlook for calcitriol across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the c...
January 2026
287 pages
The 2027-2032 World Outlook for Carglumic Acid Tablets
US$ 1,195.00
This study covers the world outlook for carglumic acid tablets across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E....
January 2026
287 pages
The 2027-2032 World Outlook for Children's Medicines
US$ 1,195.00
This study covers the world outlook for children's medicines across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.),...
January 2026
288 pages
The 2027-2032 World Outlook for Clozapine
US$ 1,195.00
This study covers the world outlook for clozapine across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the co...
January 2026
287 pages
The 2027-2032 World Outlook for Constipation Treatments
US$ 1,195.00
This study covers the world outlook for constipation treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E...
January 2026
287 pages
The 2027-2032 World Outlook for Controlled Substances
US$ 1,195.00
This study covers the world outlook for controlled substances across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.)...
January 2026
288 pages
The 2027-2032 World Outlook for Corneal Ulcer Treatments
US$ 1,195.00
This study covers the world outlook for corneal ulcer treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I....
January 2026
287 pages
The 2027-2032 World Outlook for Cough Remedies
US$ 1,195.00
This study covers the world outlook for cough remedies across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for t...
January 2026
287 pages
The 2027-2032 World Outlook for Crohn's Disease Drugs
US$ 1,195.00
This study covers the world outlook for Crohn's disease drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.)...
January 2026
287 pages
The 2027-2032 World Outlook for Crohn's Disease Therapeutics
US$ 1,195.00
This study covers the world outlook for Crohn's disease therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (...
January 2026
288 pages
The 2027-2032 World Outlook for Curcumin Pharmaceuticals
US$ 1,195.00
This study covers the world outlook for curcumin pharmaceuticals across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I....
January 2026
287 pages
The 2027-2032 World Outlook for Cycloplegic Agents
US$ 1,195.00
This study covers the world outlook for cycloplegic agents across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), f...
January 2026
287 pages
The 2027-2032 World Outlook for Cystic Fibrosis Therapeutics
US$ 1,195.00
This study covers the world outlook for cystic fibrosis therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (...
January 2026
287 pages
The 2027-2032 World Outlook for Depression Drugs
US$ 1,195.00
This study covers the world outlook for depression drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for...
January 2026
287 pages
The 2027-2032 World Outlook for Dermatitis Drugs
US$ 1,195.00
This study covers the world outlook for dermatitis drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for...
January 2026
287 pages
The 2027-2032 World Outlook for Dermatology Therapeutics
US$ 1,195.00
This study covers the world outlook for dermatology therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I....
January 2026
287 pages
